News
RGEN
165.01
-0.45%
-0.75
BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Ulta Beauty, Victoria's Secret
Reuters · 3h ago
BUZZ-U.S. STOCKS ON THE MOVE-Hewlett Packard, SentinelOne, gold miners
Reuters · 5h ago
Weekly Report: what happened at RGEN last week (1124-1128)?
Weekly Report · 4d ago
REPLIGEN CORP <RGEN.O>: HSBC RAISES TARGET PRICE TO $190 FROM $180
Reuters · 4d ago
Repligen CEO Olivier Loeillot Reports Disposal of Common Shares
Reuters · 11/26 21:31
A Look at Repligen’s (RGEN) Valuation Following Recent Share Price Gains
Simply Wall St · 11/24 10:27
Weekly Report: what happened at RGEN last week (1117-1121)?
Weekly Report · 11/24 10:15
P/E Ratio Insights for Repligen
Benzinga · 11/21 18:00
Why Repligen (RGEN) Stock Is Trading Up Today
Barchart · 11/21 17:44
Repligen’s COO Makes a Significant Stock Sale!
TipRanks · 11/20 02:06
Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron
Dow Jones · 11/19 23:21
Weekly Report: what happened at RGEN last week (1110-1114)?
Weekly Report · 11/17 10:15
Director’s Multi-Million Dollar Stock Sale Shakes Up Repligen!
TipRanks · 11/15 02:11
Q/C Technologies Delays Quarterly Financial Report Filing
Reuters · 11/14 21:56
Q/C Technologies Inc. Held Special Shareholder Meeting
Reuters · 11/14 21:55
Repligen Director Anthony Hunt Reports Sale of Common Shares
Reuters · 11/14 21:35
Repligen: Rare Growth In The Biopharma Supplies Industry
Seeking Alpha · 11/14 08:28
Repligen Director Cashes In on Massive Stock Sale!
TipRanks · 11/14 02:06
Repligen Director Anthony Hunt Reports Disposal of Common Shares
Reuters · 11/13 21:30
Sartorius: Consistent Performance And Market Resurgence - Valuation Falls
Seeking Alpha · 11/13 14:54
More
Webull provides a variety of real-time RGEN stock news. You can receive the latest news about Repligen through multiple platforms. This information may help you make smarter investment decisions.
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.